Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Osimertinib linked to cardiac events in NSCLC patients
Osimertinib linked to cardiac events in NSCLC patients
26 Nov 2025 bởiStephen Padilla

Patients with non-small cell lung cancer (NSCLC) treated with osimertinib have a higher risk of QT prolongation, reduced ejection fraction, and high-grade cardiac failure than those who received placebo or other standard therapies, reports a study.

Osimertinib linked to cardiac events in NSCLC patients
26 Nov 2025
Can indoleacetic acid help overcome P. vulgatus–induced IO resistance in HCC?
Can indoleacetic acid help overcome P. vulgatus–induced IO resistance in HCC?
25 Nov 2025 bởiNatalia Reoutova

Researchers from the University of Hong Kong (HKU) have identified enrichment in Phocaeicola vulgatus as a potential cause for immunotherapy (IO) resistance in patients with hepatocellular carcinoma (HCC) and shown Sthat supplementation with indoleacetic acid (IAA) can overcome P. vulgatus–induced immunosuppression, thereby establishing a causal relationship between P. vulgatus and anti–PD-1 resistance in HCC.

Can indoleacetic acid help overcome P. vulgatus–induced IO resistance in HCC?
25 Nov 2025